Do you want to read an article? Please log in or register.
Donor Diabetes and 1-Year Descemet Membrane Endothelial Keratoplasty Success Rate: A Randomized Clinical Trial
Further Publications
Related content
Cornea and Corneal DiseasesFurther Publications
Endothelial Cell Loss 1 Year After Successful DMEK in the Diabetes Endothelial Keratoplasty Study: A Randomized Clinical Trial
JAMA Ophthalmol
Lass JH, Benetz BA, Verdier DD, Szczotka-Flynn LB, Bauza CE, Reed ZW, Greiner MA, Mian SI, Patel SV, Pramanik S, Price FW Jr, Soper MC, Terry MA, Titus MS, Kollman C, Beck RW, Price MO, Diabetes Endothelial Keratoplasty Study Group
doi: 10.1001/jamaophthalmol.2025.4261
Cornea and Corneal Diseases
Comparative Analysis of Descemet Membrane Endothelial Keratoplasty (DMEK) Versus Descemetorhexis Without Keratoplasty (DSO) in Patients with Fuchs Endothelial Corneal Dystrophy
J Clin Med
Díaz-Mesa V, Sánchez-Ventosa Á, González-Cruces T, Membrillo A, Villalba-González M, Villarrubia A, Cano-Ortiz A
doi: 10.3390/jcm14144857
Retinal Diseases
Rates, Risk Factors, and Progression of Diabetic Retinopathy in Children with Type 1 Diabetes: A 15-Year Retrospective Study from a Regional Center in New Zealand
Pediatr Diabetes
Winter T, Derraik JGB, Jefferies CA, Hofman PL, Shand JAD, Braatvedt GD, Misra SL
doi: 10.1155/2024/5893771
Retinal Diseases
Effect of a Multifactorial Intervention on Retinopathy in People With Type 2 Diabetes: A Secondary Analysis of the J-DOIT3 Randomized Clinical Trial
JAMA Ophthalmol
Sasako T, Ueki K, Miyoshi K, Miyake K, Aoyama T, Okazaki Y, Ishizuka N, Yamauchi T, Noda M, Kadowaki T, J-DOIT3 Study Group
doi: 10.1001/jamaophthalmol.2025.3819
Surgery and InterventionFurther Publications
Anterior segment optical coherence tomography (AS-OCT) assisted analysis of characteristics of graft dehiscence after Descemet membrane endothelial keratoplasty (DMEK) for failed penetrating keratoplasty
Acta Ophthalmol
Vishwakarma P, Mestanoglu M, Welge-Lüßen V, Schlereth S, Cursiefen C, Bachmann B
doi: 10.1111/aos.17445
Macular DiseasesRetinal Diseases
Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial
JAMA Ophthalmol
Pieramici DJ, Awh CC, Chang M, Emanuelli A, Holekamp NM, Hu AY, Suñer IJ, Wykoff CC, Brittain C, Howard D, Quezada-Ruiz C, Santhanakrishnan A, Latkany P
doi: 10.1001/jamaophthalmol.2025.0001
Glaucoma and Ocular PressureCataracts
Two-Year Outcomes of Phacogoniotomy vs Phacotrabeculectomy for Advanced Primary Angle-Closure Glaucoma With Cataract: A Noninferiority Randomized Clinical Trial
JAMA Ophthalmol
Song Y, Fan S, Tang L, Lin F, Li F, Lv A, Li X, Wen T, Lu L, Xiao M, Xie L, Zhu X, Tang G, Zhang H, Yan X, Yuan H, Song W, Yang Y, Xu J, Zhou F, Wang Z, Jin L, Liang X, Zhou M, Zhao X, Chen W, Park KH, Barton K, Aung T, Tham CC, Lam DSC, Weinreb RN, Wang N, Zhang X, PVP Study Group
doi: 10.1001/jamaophthalmol.2025.0685
RECOMMENDED
Further Publications
Efficacy and Safety of Different Atropine Regimens for the Treatment of Myopia in Children: Three-Year Results of the MOSAIC Randomized Clinical Trial
★ 3
Recommended by
Prof. Dr Ke Yao, Faculty Member
JAMA Ophthalmol
Loughman J, Lingham G, Nkansah EK, Kobia-Acquah E, Flitcroft DI
doi: 10.1001/jamaophthalmol.2024.5703
Macular Diseases
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial
JAMA Ophthalmol
Khanani AM, Campochiaro PA, Graff JM, Marcus DM, Miller D, Mittra RA, Regillo C, Sheth VS, Bobbala A, Gune S, Lin S, Quezada-Ruiz C, Malhotra V
doi: 10.1001/jamaophthalmol.2025.0006